Medication for children with attentional disorders

Pediatrics

Volumn 98, Issue 2, 1996, Pages 301-303

  Perrin, J ^a   Erenberg, G ^a   La Camera, R ^a   Nackashi, J A ^a   Poncher, J R ^a   Randall, V ^a   Ruppert, E ^a   Wachtel, R C ^a   Ziring, P R ^a   Arango, P ^a   Gaebler Spira, D J ^a   Garner, C ^a   Garro, D ^a   Mather, J H ^a   Hollowell, J G ^a   McPherson, M ^a   Gewanter, H ^a   Berlin C M , Jr ^a   May, D G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; IMIPRAMINE; METHYLPHENIDATE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

APPETITE DISORDER; ATTENTION DEFICIT DISORDER; CHILD; DRUG CHOICE; DRUG INDICATION; DRUG USE; HEADACHE; HUMAN; INSOMNIA; PRIORITY JOURNAL; REVIEW; STOMACH PAIN;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLONIDINE; HUMANS; PEDIATRICS; SOCIETIES, MEDICAL;

EID: 9344223922     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry. 1937;94:577-585
2. Sulzbacher SI. Psychotropic medication with children: an evaluation of procedural biases in results of reported studies. Pediatrics. 1973;51:513-517
3. American Academy of Pediatrics, Committee on Children with Disabilities and Committee on Drugs. Medication for children with an attention deficit disorder. Pediatrics. 1987;80:758-760
4. American Academy of Pediatrics, Committee on Children with Disabilities. AAP defines attention-deficit hyperactivity disorders. AAP News. 1991;7:12-13
5. American Academy of Pediatrics, Council on Child Health. Medication for hyperkinetic children. Pediatrics. 1975;55:560-562
6. McDaniel KD. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents. Part 1. Clin Pediatr (Phila). 1986;25:65-71
7. Culbert TP, Banez GA, Reiff MI. Children who have attentional disorders: interventions. Pediatr Rev. 1994;15:5-14
8. Sprague RL, Sleator EK. Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science. 1977;198:1274-1276
9. Ottenbacher KJ, Cooper HM. Drug treatment of hyperactivity in children. Dev Med Child Neurol. 1983;25:358-366
10. Sallee FR, Stiller RL, Perel JM. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1992;31:244-251
11. Berkley RA, DuPaul GJ, McMurray MB. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Pediatrics. 1991;87:519-531
12. Conners CK. Rating scales for use in drug studies with children. Psychopharmacol Bull. 1973(special issue):24-29
13. Ottinger DR, Halpin B, Miller M, et al. Evaluating drug effectiveness in an office setting for children with attention deficit disorders. Clin Pediatr (Phila). 1985;24:245-251
14. Davy T, Rodgers CL. Stimulant medication and short attention span: a clinical approach. J Dev Behav Pediatr. 1989;10:313-318
15. Pelham WE Jr, Sturges J, Hoza J, et al. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics. 1987;80:491-501
16. Pliszka SR. Tricyclic antidepressants in the treatment of children with attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1987;26: 127-132
17. Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry. 1993;32:792-797
18. Biederman J, Baldessarini RJ, Goldblatt A, et al. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry. 1993;32:805-813
19. Wilens TE, Biederman J, Baldessarini RJ, et al. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. J Am Acad Child Adolesc Psychiatry. 1993;32:798-804
20. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Adolesc Psychiatry. 1985;24:617-629
21. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86: 184-192
22. Kalachnik JE, Sprague RL, Sleator EK, Cohen MN, Ullmann RK. Effect of methylphenidate hydrochloride on stature of hyperactive children. Dev Med Child Neurol. 1982;24:586-595
23. Erenberg G, Cruse RP, Rothner AD. Gilles de la Tourette syndrome: effects of stimulant drugs. Neurology. 1985;35:1346-1348
24. Safer DJ, Krager JM. A survey of medication treatment for hyperactive/ inattentive students. JAMA. 1988;260:2256-2258